Atea Pharmaceuticals
Price & Volume
Stats
See moreOpen | $3.11 |
Previous Close | $3.13 |
Day Range | $3.01-$3.15 |
52W Range | $2.45-$4.02 |
Market Cap | $248.3M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $192.1M |
Revenue Growth (YoY) | 295.2% |
Gross Profit (12 Mos) | -$77.1M |
Diluted EPS | -$1.62 |
News
See moreYahoo Finance • 2 months ago
Atea Pharmaceuticals Q2 2025 slides: HCV program advances with Phase 3 trials underway
Yahoo Finance • 2 months ago
Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
About
CEO | Dr. Jean-Pierre Sommadossi Ph.D. |
CFO | Ms. Andrea J. Corcoran J.D. |
Address | 225 Franklin Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 56 |
